and Extra Pharmacopoeia NAME: AYAN MAJI ROLL NO: 38405923012 REG NO: 233840210012 SUBJECT: PHARMACEUTICS-I SESSION: 2023-2024 CONTENT 1.PHARMACOPOEIA 2.INDIAN PHARMACOPOEIA (IP) 3.BRITISH PHARMACOPOEIA (BP) 4.UNITED STATES PHARMACOPOEIA (USP) 5.EXTRA PHARMACOPOEIA (EP) 6.CONCLUSION 7.REFERENCE CONCLUSION Pharmacopeia typically summarizes the standards and guidelines for the preparation, quality control, and use of pharmaceutical substances and dosage forms. It may also include information on regulatory requirements, storage conditions, and labeling. Pharmacopeia serves as a vital reference for pharmaceutical professionals, regulatory authorities, and other stakeholders involved in the development, manufacturing, and quality control of medicinal products. It provides a comprehensive set of standards and guidelines aimed at ensuring the quality, safety, and efficacy of pharmaceuticals for the benefit of patients and healthcare providers. REFERENCE “Pharmaceutical Preformulation and Formulation: A Practical Guide from Candidate Drug Selection to Commercial Dosage Form” by Mark Gibson